Rumble J - Search Results

1

Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.

Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K, Chou ST. Cooper ME, et al. Among authors: rumble j. Diabetes. 1994 Oct;43(10):1221-8. doi: 10.2337/diab.43.10.1221. Diabetes. 1994. PMID: 7926292

2

Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.

Rumble JR, Doyle AE, Cooper ME. Rumble JR, et al. Am J Hypertens. 1995 Jan;8(1):53-7. doi: 10.1016/0895-7061(94)00165-8. Am J Hypertens. 1995. PMID: 7734098

3

Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.

Allen TJ, Hulthen UL, Rumble JR, Jasik M, Cooper ME. Allen TJ, et al. Among authors: rumble jr. J Diabetes Complications. 1995 Oct-Dec;9(4):318-22. doi: 10.1016/1056-8727(95)80031-9. J Diabetes Complications. 1995. PMID: 8573756

4

Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.

Rumble JR, Komers R, Cooper ME. Rumble JR, et al. J Hypertens. 1996 May;14(5):601-7. doi: 10.1097/00004872-199605000-00009. J Hypertens. 1996. PMID: 8762203

5

Diabetic vascular injury and ACE. Potential for pharmacological prevention of complications of later life.

Cooper ME, Vranes D, Rumble JR. Cooper ME, et al. Among authors: rumble jr. Drugs Aging. 1996 Jan;8(1):38-46. doi: 10.2165/00002512-199608010-00007. Drugs Aging. 1996. PMID: 8785467 Review.

6

Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.

Hulthén UL, Cao Z, Rumble JR, Cooper ME, Johnston CI. Hulthén UL, et al. Among authors: rumble jr. Am J Hypertens. 1996 Sep;9(9):895-901. doi: 10.1016/s0895-7061(96)00177-x. Am J Hypertens. 1996. PMID: 8879346

7

Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy.

Rumble JR, Gilbert RE, Cox A, Wu L, Cooper ME. Rumble JR, et al. J Hypertens. 1998 Nov;16(11):1603-9. doi: 10.1097/00004872-199816110-00006. J Hypertens. 1998. PMID: 9856360

8

Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies.

Cooper ME, Cao Z, Rumble JR, Jandeleit K, Allen TJ, Gilbert RE. Cooper ME, et al. Among authors: rumble jr. Metabolism. 1998 Dec;47(12 Suppl 1):24-7. doi: 10.1016/s0026-0495(98)90367-5. Metabolism. 1998. PMID: 9867067

9

Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition.

Jandeleit-Dahm K, Hannan KM, Farrelly CA, Allen TJ, Rumble JR, Gilbert RE, Cooper ME, Little PJ. Jandeleit-Dahm K, et al. Among authors: rumble jr. Circ Res. 2000 Dec 8;87(12):1133-40. doi: 10.1161/01.res.87.12.1133. Circ Res. 2000. PMID: 11110770

10

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.

Gilbert RE, Kelly DJ, Cox AJ, Wilkinson-Berka JL, Rumble JR, Osicka T, Panagiotopoulos S, Lee V, Hendrich EC, Jerums G, Cooper ME. Gilbert RE, et al. Among authors: rumble jr. Diabetologia. 2000 Nov;43(11):1360-7. doi: 10.1007/s001250051539. Diabetologia. 2000. PMID: 11126403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters